Peptide Library

GLP-1 receptor agonist with extensive Phase 3 trial data for type 2 diabetes and chronic weight management. Prescription-only in most jurisdictions.

Dual GIP / GLP-1 receptor agonist with strong Phase 3 evidence in type 2 diabetes (SURPASS) and obesity (SURMOUNT).

Immunomodulatory peptide approved in some countries (e.g., for hepatitis B). Studied in immune modulation contexts.

Copper tripeptide studied in dermatology for skin remodeling and wound contexts. Topical formulations are widely used in cosmetics.

A pentadecapeptide derived from a sequence in human gastric juice. Most existing data is preclinical (animal models), exploring tissue repair, gut barrier, and tendon healing.

Growth-hormone secretagogue combination studied for stimulating endogenous GH pulses in research contexts.

Heptapeptide analog of ACTH(4-10) studied in Russia for cognitive and neuroprotective effects after stroke.

Synthetic fragment related to thymosin beta-4. Investigated in animal studies for cellular migration and tissue remodeling.

Tetrapeptide studied primarily in Russian gerontology research for telomerase modulation and pineal function.

Synthetic analog of a fragment of human tuftsin, studied in Russia for anxiolytic and nootropic effects.

Tripeptide derivative of α-MSH studied in animal models of intestinal and skin inflammation.

Delta sleep-inducing peptide originally isolated in studies of EEG slow-wave activity. Modern human data is sparse.